Nevada Biotechnology & Bioscience Corporation

Fiscal year ending 2023. Filed on October 14, 2024.

9501 Royal Windsor Ave
Las Vegas, Nevada 89149

Nevada Biotechnology & Bioscience Corporation (EIN: 26-0681229) has filed an IRS Form 990 between fiscal years 2021 and 2023. In its fiscal year 2023 IRS Form 990 filing, Nevada Biotechnology & Bioscience Corporation, a 501(c)(6) business league, reported compensation for 2 employees. Among the employees shown here, the average compensation is $31,825. The highest compensated employee at Nevada Biotechnology & Bioscience Corporation is John Laub with fiscal year 2023 compensation of $43,350.

Revenue, expenses, and employee compensation

Revenue

$146,041

Expenses

$91,414

Employee compensation

Revenue, expenses, and employee compensation over time

Mission Statement

Raise awareness of biotechnology in Nevada

Revisions to this organization profile

October 14, 2024:
2023 Nevada Biotechnology & Bioscience Corporation 990 filed
November 13, 2023:
2022 Nevada Biotechnology & Bioscience Corporation 990 filed
May 30, 2022:
2021 Nevada Biotechnology & Bioscience Corporation 990 filed

Get an email when new compensation information is released for Nevada Biotechnology & Bioscience Corporation

Be the first to know when new IRS Form 990 data is published for this organization.

Related Jobs

Powered by Talroo